A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels

Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

OBJECTIVE: Recent studies have demonstrated an association between a 192 bp polymorphism of the IGF-I gene and total IGF-I serum levels, birth weight, body height and the risk of developing diabetes and cardiovascular diseases later on in life. This IGF-I gene polymorphism in the promoter region of the IGF-I gene may directly influence the expression of IGF-I. In the present study we evaluated the role of this polymorphism in the age-related decline in serum IGF-I levels. SUBJECTS AND METHODS: All subjects were participants of the Rotterdam Study, a population-based cohort study of diseases in the elderly. We studied a total group of 346 subjects, who comprised two subgroups: a randomly selected population-based sample of 196 subjects, and a group of 150 subjects selected on IGF-I genotype. In the total group of 346 individuals the relationship between this 192 bp polymorphism and the age-related decline in circulating total IGF-I levels was studied. RESULTS: Homozygous carriers of the 192 bp allele demonstrated significant decline in serum IGF-I with age (r=-0.29, P=0.002). This decline is similar to that seen in the general population. An age-related decline in serum total IGF-I was not observed in heterozygotes (r=-0.06, P=0.48) and non-carriers (r = -0.12, P=0.32). Interestingly, the relationship between age and serum IGF-binding protein-3 levels showed the same pattern. CONCLUSION: We observed only in homozygous carriers of the 192 bp alleles of the IGF-I gene an age-related decline in circulating total IGF-I levels, but not in heterozygotes and non-carriers of the 192 bp allele. We hypothesize that this IGF-I gene polymorphism directly or indirectly influences GH-mediated regulation of IGF-I secretion.

This article has been cited by other articles:

				Y. Okada, Y. Kamatani, A. Takahashi, K. Matsuda, N. Hosono, H. Ohmiya, Y. Daigo, K. Yamamoto, M. Kubo, Y. Nakamura, et al. A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci Hum. Mol. Genet., March 10, 2010; (2010) ddq091v2. [Abstract] [Full Text] [PDF]

				W. A Ester, J. B van Meurs, N. J Arends, A. G Uitterlinden, M. A de Ridder, and A. C Hokken-Koelega The -G1245A IGF1 polymorphism is related with small head size and less brain sparing in small for gestational age born children Eur. J. Endocrinol., April 1, 2009; 160(4): 549 - 555. [Abstract] [Full Text] [PDF]

				A. A. D'Aloisio, J. C. Schroeder, K. E. North, C. Poole, S. L. West, G. S. Travlos, and D. D. Baird IGF-I and IGFBP-3 Polymorphisms in Relation to Circulating Levels among African American and Caucasian Women Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 954 - 966. [Abstract] [Full Text] [PDF]

				V. A A van Houten, D. O Mook-Kanamori, L. van Osch-Gevers, E. A P Steegers, A. Hofman, H. A Moll, C. M van Duijn, W. A Helbing, A. C S Hokken-Koelega, and V. W V Jaddoe A variant of the IGF-I gene is associated with blood pressure but not with left heart dimensions at the age of 2 years: the Generation R Study Eur. J. Endocrinol., September 1, 2008; 159(3): 209 - 216. [Abstract] [Full Text] [PDF]

				W. Hernandez, C. Grenade, E. R. Santos, C. Bonilla, C. Ahaghotu, and R. A. Kittles IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans Carcinogenesis, October 1, 2007; 28(10): 2154 - 2159. [Abstract] [Full Text] [PDF]

				P. Hovind, S. Lamberts, W. Hop, J. Deinum, L. Tarnow, H.-H. Parving, and J. A M J L Janssen An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes Eur. J. Endocrinol., January 1, 2007; 156(1): 83 - 90. [Abstract] [Full Text] [PDF]

				I Rietveld, A Hofman, H A P Pols, C M van Duijn, S W J Lamberts, and J A M J L Janssen An insulin-like growth factor-I gene polymorphism modifies the risk of microalbuminuria in subjects with an abnormal glucose tolerance. Eur. J. Endocrinol., May 1, 2006; 154(5): 715 - 721. [Abstract] [Full Text] [PDF]

				T. Munzer, C. J. Rosen, S.M. Harman, K. M. Pabst, C. St. Clair, J. D. Sorkin, and M. R. Blackman Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E1006 - E1013. [Abstract] [Full Text] [PDF]

				R. J. Cleveland, M. D. Gammon, S. N. Edmiston, S. L. Teitelbaum, J. A. Britton, M. B. Terry, S. M. Eng, A. I. Neugut, R. M. Santella, and K. Conway IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project Carcinogenesis, April 1, 2006; 27(4): 758 - 765. [Abstract] [Full Text] [PDF]

				P. G Voorhoeve, E. F C van Rossum, S. J te Velde, J. W Koper, H. C G Kemper, S. W J Lamberts, and H. A D.-v. de Waal Association between an IGF-I gene polymorphism and body fatness: differences between generations. Eur. J. Endocrinol., March 1, 2006; 154(3): 379 - 388. [Abstract] [Full Text] [PDF]

				M. Zecevic, C. I. Amos, X. Gu, I. M. Campos, J. S. Jones, P. M. Lynch, M. A. Rodriguez-Bigas, and M. L. Frazier IGF1 Gene Polymorphism and Risk for Hereditary Nonpolyposis Colorectal Cancer J Natl Cancer Inst, January 18, 2006; 98(2): 139 - 143. [Abstract] [Full Text] [PDF]

				M J E van Rijn, A J C Slooter, M J Bos, C F B S Catarino, P J Koudstaal, A Hofman, M M B Breteler, and C M van Duijn Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 24 - 27. [Abstract] [Full Text] [PDF]

				M. C. Kostek, M. J. Delmonico, J. B. Reichel, S. M. Roth, L. Douglass, R. E. Ferrell, and B. F. Hurley Muscle strength response to strength training is influenced by insulin-like growth factor 1 genotype in older adults J Appl Physiol, June 1, 2005; 98(6): 2147 - 2154. [Abstract] [Full Text] [PDF]

				S Mohan and D J Baylink Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences J. Endocrinol., June 1, 2005; 185(3): 415 - 420. [Abstract] [Full Text] [PDF]

				L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1394 - 1401. [Abstract] [Full Text] [PDF]

				J. M. Schildkraut, W. Demark-Wahnefried, R. M. Wenham, J. Grubber, A. S. Jeffreys, S. C. Grambow, J. R. Marks, P. G. Moorman, C. Hoyo, S. Ali, et al. IGF1 (CA)19 Repeat and IGFBP3 -202 A/C Genotypes and the Risk of Prostate Cancer in Black and White Men Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 403 - 408. [Abstract] [Full Text] [PDF]

				G S Bleumink, A F C Schut, M C J M Sturkenboom, J A M J L Janssen, J C M Witteman, C M van Duijn, A Hofman, and B H C. Stricker A promoter polymorphism of the insulin-like growth factor-I gene is associated with left ventricular hypertrophy Heart, February 1, 2005; 91(2): 239 - 240. [Full Text] [PDF]

				O. Fletcher, L. Gibson, N. Johnson, D. R. Altmann, J. M.P. Holly, A. Ashworth, J. Peto, and I. d. S. Silva Polymorphisms and Circulating Levels in the Insulin-Like Growth Factor System and Risk of Breast Cancer: A Systematic Review Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 2 - 19. [Abstract] [Full Text] [PDF]

				H.-L. Wong, K. DeLellis, N. Probst-Hensch, W.-P. Koh, D. Van Den Berg, H.-P. Lee, M. C. Yu, and S. A. Ingles A New Single Nucleotide Polymorphism in the Insulin-Like Growth Factor I Regulatory Region Associates with Colorectal Cancer Risk in Singapore Chinese Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 144 - 151. [Abstract] [Full Text] [PDF]

				M. Rosilio, W. F. Blum, D. J. Edwards, E. P. Shavrikova, D. Valle, S. W. J. Lamberts, E. M. Erfurth, S. M. Webb, R. J. Ross, K. Chihara, et al. Long-Term Improvement of Quality of Life During Growth Hormone (GH) Replacement Therapy in Adults with GH Deficiency, as Measured by Questions on Life Satisfaction-Hypopituitarism (QLS-H) J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1684 - 1693. [Abstract] [Full Text] [PDF]

				C. Livingstone and G. A. Ferns Review: Insulin-like growth factor-related proteins and diabetic complications The British Journal of Diabetes & Vascular Disease, September 1, 2003; 3(5): 326 - 331. [Abstract] [PDF]

				F. Rivadeneira, J. J. Houwing-Duistermaat, N. Vaessen, J. M. Vergeer-Drop, A. Hofman, H. A. P. Pols, C. M. van Duijn, and A. G. Uitterlinden Association between an Insulin-Like Growth Factor I Gene Promoter Polymorphism and Bone Mineral Density in the Elderly: The Rotterdam Study J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3878 - 3884. [Abstract] [Full Text] [PDF]